CFTR and cystic fibrosis: DAP has been successfully tested on mice, organoids derived from murine or patient cells, and in cells from CF patients, resulting in the ability to restore the expression and functionality of the nonsense‐mutated CFTR gene, which presents UGA as a PTC.